Clinical Trial Update: Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating the interaction between two long-acting reversible contraception methods and dolutegravir for HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Human Immunodeficiency Virus

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Botswana Harvard AIDS Institute Partnership | Conditions: Human Immunodeficiency Virus, Contraception | Phase 4 | Status: UNKNOWN